US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alpha Healthcare Acquisition Corp

10.96

0.0000

Volume:- -

Turnover:- -

Market Cap:140.89M

PE:-71.87

High:10.96

Open:10.96

Low:10.96

Close:10.96

Loading ...

Overview Company News Filings

BRIEF-Alpha Healthcare Acquisition Corp. Announces Shareholder Approval Of Business Combination With Humacyte

Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on Humacyte Business Combination

BRIEF-Alpha Healthcare Acquisition Corp III Announces Pricing Of $150 Million Initial Public Offering

Humacyte Presents Potential of Functional Lung Engineering at Janelia R3 – Replace, Repair, Regenerate Planning Workshop

Alpha Healthcare Acquisition started at buy with $18 stock price target at Benchmark

Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment

Humacyte Receives 2021 Life Sciences Award from Triangle Business Journal

Humacyte Presents Advances in Whole-Lung Engineering

Humacyte Appoints Dale Sander as Chief Financial Officer

What Is The Ownership Structure Like For Alpha Healthcare Acquisition Corp. (NASDAQ:AHAC)?

Simply Wall St.

Humacyte Announces Positive Long-Term Follow-Up Data from Phase 2 Vascular Access Trial

Humacyte Secures $50 Million Debt Facility with Silicon Valley Bank

Humacyte to Present at Oppenheimer 31st Annual Healthcare Conference

Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021

BRIEF-Blank Check Company Alpha Healthcare Acquisition Corp III Files For IPO Of Up To $150 Million – SEC Filing

BRIEF-Humacyte Going Public Via Merger With Alpha Healthcare Acquisition Corp

Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.

Human tissue developer Humacyte nears SPAC deal to go public - sources

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AHAC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AHAC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AHAC\",,,,,undefined,":{"symbol":"AHAC","market":"US","secType":"STK","nameCN":"Alpha Healthcare Acquisition Corp","latestPrice":10.96,"timestamp":1630008000000,"preClose":10.96,"halted":8,"volume":0,"delay":0,"floatShares":9510266,"shares":12855000,"eps":-0.152489,"marketStatus":"Market Closed","change":0,"latestTime":"08-26 16:00:00 EDT","open":10.96,"high":10.96,"low":10.96,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.152489,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"HUMA","executeDate":"2021-08-27"},"adr":0,"exchange":"NASDAQ","adjPreClose":10.96,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AHAC\",,,,,undefined,":{"symbol":"AHAC","floatShares":9510266,"roa":"--","roe":"--","lyrEps":-0.076244,"shares":12855000,"dividePrice":0,"high":10.96,"amplitude":0,"preClose":10.96,"low":10.96,"week52Low":9.12,"pbRate":"28.18","week52High":16.9599,"institutionHeld":0,"latestPrice":10.96,"eps":-0.152489,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.152489,"open":10.96},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AHAC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2162082383","title":"BRIEF-Alpha Healthcare Acquisition Corp. Announces Shareholder Approval Of Business Combination With Humacyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2162082383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2162082383?lang=en_us&edition=fundamental","pubTime":"2021-08-25 01:00","pubTimestamp":1629824411,"startTime":"0","endTime":"0","summary":"Aug 24 (Reuters) - Alpha Healthcare Acquisition Corp :   * ALPHA HEALTHCARE ACQUISITION CORP. ANNOUNCES SHAREHOLDER APPROVAL OF BUSINESS COMBINATION WITH HUMACYTESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","AHAC","AHACU"],"gpt_icon":0},{"id":"2157497483","title":"Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on Humacyte Business Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2157497483","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2157497483?lang=en_us&edition=fundamental","pubTime":"2021-08-05 04:53","pubTimestamp":1628110380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alpha-healthcare-acquisition-corp-sets-205300371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HR","HCSG","AHACW","AHACU","AHAC"],"gpt_icon":0},{"id":"2154696264","title":"BRIEF-Alpha Healthcare Acquisition Corp III Announces Pricing Of $150 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2154696264","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2154696264?lang=en_us&edition=fundamental","pubTime":"2021-07-27 06:50","pubTimestamp":1627339846,"startTime":"0","endTime":"0","summary":"July 26 (Reuters) - Alpha Healthcare Acquisition Corp :   * . III ANNOUNCES PRICING OF $150 MILLION INITIAL PUBLIC OFFERING   * PRICED ITS INITIAL PUBLIC OFFERING OF 15,000,000 UNITS AT $10.00 PER UNITSource text for Eikon:    Further company coverage:    ((reuters.briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HR","HCSG","AHAC","AHACU","AHACW","ALPAU"],"gpt_icon":0},{"id":"2153676342","title":"Humacyte Presents Potential of Functional Lung Engineering at Janelia R3 – Replace, Repair, Regenerate Planning Workshop","url":"https://stock-news.laohu8.com/highlight/detail?id=2153676342","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2153676342?lang=en_us&edition=fundamental","pubTime":"2021-07-22 19:30","pubTimestamp":1626953400,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., July 22, 2021  -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announces that Laura Niklason, M.D., Ph.D., Chief Executive Officer, delivered an invited presentation on laboratory and preclinical findings and notable criteria for engineering functional air sacs in the lungs, which support the potential to create engineered lung tissue organ, at the virtual Janelia R3 – Replac","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-presents-potential-functional-lung-113000502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHAC","AHACW","AHACU"],"gpt_icon":0},{"id":"2152660582","title":"Alpha Healthcare Acquisition started at buy with $18 stock price target at Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2152660582","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2152660582?lang=en_us&edition=fundamental","pubTime":"2021-07-20 18:27","pubTimestamp":1626776820,"startTime":"0","endTime":"0","summary":"MW Alpha Healthcare Acquisition started at buy with $18 stock price target at Benchmark\n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 20, 2021 06:27 ET (10:27 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HR","AHACU","HCSG","AHAC"],"gpt_icon":0},{"id":"2142203838","title":"Humacyte Expands Strategic Global Partnership with Fresenius Medical Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2142203838","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2142203838?lang=en_us&edition=fundamental","pubTime":"2021-06-11 19:30","pubTimestamp":1623411000,"startTime":"0","endTime":"0","summary":"Partnership expanded to include vascular trauma repair outside of the United States.Fresenius Medical Care will adopt the HAV as a standard of care in patients who will benefit from clinical and economic perspectives.Fresenius Medical Care is a leading participant in fully committed PIPE financing transaction.DURHAM, N.C., June 11, 2021  -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, announces ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-expands-strategic-global-partnership-113000743.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHACU","AHAC"],"gpt_icon":0},{"id":"2141426944","title":"Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2141426944","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2141426944?lang=en_us&edition=fundamental","pubTime":"2021-06-08 19:30","pubTimestamp":1623151800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-presents-vivo-data-biovascular-113000717.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHACU","AHAC"],"gpt_icon":0},{"id":"2138311287","title":"Humacyte Receives 2021 Life Sciences Award from Triangle Business Journal","url":"https://stock-news.laohu8.com/highlight/detail?id=2138311287","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2138311287?lang=en_us&edition=fundamental","pubTime":"2021-05-26 19:30","pubTimestamp":1622028600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-receives-2021-life-sciences-113000835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHACU","AHAC","DMTK"],"gpt_icon":0},{"id":"2137092399","title":"Humacyte Presents Advances in Whole-Lung Engineering","url":"https://stock-news.laohu8.com/highlight/detail?id=2137092399","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2137092399?lang=en_us&edition=fundamental","pubTime":"2021-05-21 19:30","pubTimestamp":1621596600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-presents-advances-whole-lung-113000640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHACU","AHAC"],"gpt_icon":0},{"id":"2136946865","title":"Humacyte Appoints Dale Sander as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2136946865","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2136946865?lang=en_us&edition=fundamental","pubTime":"2021-05-20 04:30","pubTimestamp":1621456200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-appoints-dale-sander-chief-203000701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHAC","AHACU"],"gpt_icon":0},{"id":"2133683806","title":"What Is The Ownership Structure Like For Alpha Healthcare Acquisition Corp. (NASDAQ:AHAC)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2133683806","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2133683806?lang=en_us&edition=fundamental","pubTime":"2021-05-07 19:37","pubTimestamp":1620387429,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/EkRWqzrhItVG76LcNRNXtA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/SSw8naZrBB1tKswm10P8gw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f88d3d8c5618aa88ce2627c2a1cda340","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/EkRWqzrhItVG76LcNRNXtA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/SSw8naZrBB1tKswm10P8gw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f88d3d8c5618aa88ce2627c2a1cda340"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ownership-structure-alpha-healthcare-acquisition-113709455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHACU","HR","AHAC","AHACW","HCSG"],"gpt_icon":0},{"id":"2129871584","title":"Humacyte Announces Positive Long-Term Follow-Up Data from Phase 2 Vascular Access Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2129871584","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2129871584?lang=en_us&edition=fundamental","pubTime":"2021-04-21 20:00","pubTimestamp":1619006400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-announces-positive-long-term-120000614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHAC","AHACU"],"gpt_icon":0},{"id":"2127024635","title":"Humacyte Secures $50 Million Debt Facility with Silicon Valley Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2127024635","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2127024635?lang=en_us&edition=fundamental","pubTime":"2021-04-14 19:30","pubTimestamp":1618399800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-secures-50-million-debt-113000094.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHACU","AHAC"],"gpt_icon":0},{"id":"2118982331","title":"Humacyte to Present at Oppenheimer 31st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2118982331","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118982331?lang=en_us&edition=fundamental","pubTime":"2021-03-11 20:30","pubTimestamp":1615465800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-present-oppenheimer-31st-annual-123000396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHAC","AHACU"],"gpt_icon":0},{"id":"2117963318","title":"Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2117963318","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2117963318?lang=en_us&edition=fundamental","pubTime":"2021-03-05 20:30","pubTimestamp":1614947400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kPIJjdAT0CD9SmoZC41jzQ--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Kqn8K5Vmz3uOPOZ_66yLbA--~B/aD0xMjA1O3c9NTQ4NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7a87695b5565dc6b11f7bec264773f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-present-long-term-data-123000444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHACU","CX","AHAC"],"gpt_icon":0},{"id":"2117504389","title":"BRIEF-Blank Check Company Alpha Healthcare Acquisition Corp III Files For IPO Of Up To $150 Million – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2117504389","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2117504389?lang=en_us&edition=fundamental","pubTime":"2021-03-05 05:45","pubTimestamp":1614894303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AHAC","AHACU","AHACW"],"gpt_icon":0},{"id":"2112483776","title":"BRIEF-Humacyte Going Public Via Merger With Alpha Healthcare Acquisition Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2112483776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2112483776?lang=en_us&edition=fundamental","pubTime":"2021-02-17 20:37","pubTimestamp":1613565423,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AHAC","AHACW","AHACU"],"gpt_icon":0},{"id":"2112837946","title":"Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.","url":"https://stock-news.laohu8.com/highlight/detail?id=2112837946","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2112837946?lang=en_us&edition=fundamental","pubTime":"2021-02-17 20:00","pubTimestamp":1613563200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/aC8OlJO9_aqhjZ.yqx_g6w--~B/aD0zMjEwO3c9MjU5MDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Qq5_DZFPvh6zeQxw6iDopg--~B/aD0zMjEwO3c9MjU5MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/023faf04c5ce035c31e73c94f5ced608","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/aC8OlJO9_aqhjZ.yqx_g6w--~B/aD0zMjEwO3c9MjU5MDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Qq5_DZFPvh6zeQxw6iDopg--~B/aD0zMjEwO3c9MjU5MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/023faf04c5ce035c31e73c94f5ced608"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-transformative-biotechnology-platform-company-120000205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AHACU","AHAC","AHACW"],"gpt_icon":0},{"id":"2112354458","title":"Human tissue developer Humacyte nears SPAC deal to go public - sources","url":"https://stock-news.laohu8.com/highlight/detail?id=2112354458","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2112354458?lang=en_us&edition=fundamental","pubTime":"2021-02-17 10:58","pubTimestamp":1613530715,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AHAC","MRNA"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AHAC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-08-27","symbol":"AHAC","oldSymbol":"AHAC","defaultRemindTime":1630071000000,"newSymbol":"HUMA","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1630036800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AHAC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AHAC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AHAC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AHAC","date":"2021-08-26","current":45.954534,"percent":0.863248,"low":-349.840143,"twenty":-297.942597,"median":-191.025463,"eighty":45.619497,"high":50.391524,"avg":-128.74898,"sd":169.324325,"marketCap":130478250},"quantilePoints":[{"date":"2021-02-19","current":-347.91189,"twenty":-348.352633,"median":-348.187355,"eighty":-348.022076,"marketCap":162358650},{"date":"2021-02-26","current":-316.508916,"twenty":-348.352633,"median":-316.508916,"eighty":-102.288195,"marketCap":147703950},{"date":"2021-03-05","current":-286.483266,"twenty":-346.369288,"median":-315.131593,"eighty":-145.540668,"marketCap":133692000},{"date":"2021-03-12","current":-318.988099,"twenty":-340.198879,"median":-315.131593,"eighty":-286.483266,"marketCap":148860900},{"date":"2021-03-19","current":-291.99256,"twenty":-325.654344,"median":-308.795906,"eighty":-290.890701,"marketCap":136263000},{"date":"2021-03-26","current":-291.717095,"twenty":-325.378879,"median":-303.837541,"eighty":-291.276352,"marketCap":136134450},{"date":"2021-04-01","current":-298.328248,"twenty":-320.530701,"median":-303.837541,"eighty":-291.882374,"marketCap":139219650},{"date":"2021-04-08","current":-295.573601,"twenty":-319.318656,"median":-299.154642,"eighty":-292.653675,"marketCap":137934150},{"date":"2021-04-16","current":-298.328248,"twenty":-318.492262,"median":-299.705571,"eighty":-293.645348,"marketCap":139219650},{"date":"2021-04-23","current":-284.279549,"twenty":-316.068173,"median":-298.603713,"eighty":-291.772188,"marketCap":132663600},{"date":"2021-04-30","current":-279.596649,"twenty":-314.195013,"median":-298.052783,"eighty":-284.830478,"marketCap":130478250},{"date":"2021-05-07","current":-276.015609,"twenty":-312.652411,"median":-296.399995,"eighty":-280.698508,"marketCap":128807100},{"date":"2021-05-14","current":-271.745906,"twenty":-308.244976,"median":-295.022672,"eighty":-279.596649,"marketCap":126814575},{"date":"2021-05-21","current":-272.985497,"twenty":-307.969511,"median":-294.747207,"eighty":-277.613303,"marketCap":127393050},{"date":"2021-05-28","current":-272.985497,"twenty":-306.647281,"median":-293.645348,"eighty":-275.574865,"marketCap":127393050},{"date":"2021-06-04","current":45.275403,"twenty":-305.765794,"median":-291.854827,"eighty":-273.260962,"marketCap":128550000},{"date":"2021-06-11","current":50.255698,"twenty":-304.663935,"median":-286.483266,"eighty":-271.883638,"marketCap":142690500},{"date":"2021-06-18","current":46.090361,"twenty":-304.223192,"median":-284.830478,"eighty":-108.300813,"marketCap":130863900},{"date":"2021-06-25","current":45.547056,"twenty":-303.892634,"median":-283.039958,"eighty":45.166742,"marketCap":129321300},{"date":"2021-07-02","current":46.362013,"twenty":-302.074567,"median":-280.423043,"eighty":45.565166,"marketCap":131635200},{"date":"2021-07-08","current":45.592331,"twenty":-300.862523,"median":-279.596649,"eighty":45.664772,"marketCap":129449850},{"date":"2021-07-16","current":45.41123,"twenty":-299.485199,"median":-276.291073,"eighty":45.773433,"marketCap":128935650},{"date":"2021-07-23","current":45.230128,"twenty":-299.044456,"median":-275.740144,"eighty":45.737213,"marketCap":128421450},{"date":"2021-07-30","current":45.094302,"twenty":-298.658805,"median":-273.260962,"eighty":45.664772,"marketCap":128035800},{"date":"2021-08-06","current":45.184853,"twenty":-298.328248,"median":-272.985497,"eighty":45.619497,"marketCap":128292900},{"date":"2021-08-13","current":45.184853,"twenty":-298.218062,"median":-271.883638,"eighty":45.574221,"marketCap":128292900},{"date":"2021-08-19","current":45.230128,"twenty":-297.99769,"median":-271.745906,"eighty":45.583276,"marketCap":128421450},{"date":"2021-08-26","current":45.954534,"twenty":-297.942597,"median":-191.025463,"eighty":45.619497,"marketCap":130478250}],"updateTime":1752903448113}}}